Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Epidemiology and surveillance of Gram-negative infections caused by carbapenemase-producing organisms (CPOs) in the UK
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine United Kingdom
    Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC)
    Release Date:
    Partner: ALK Positive
    Review Process: Pfizer Internal
    Education Oncology All
    Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache Disorders
    Release Date:
    Partner: American Headache Society
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine Canada, USA
    Shared Decision Making in Hemophilia Patient Care
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease China
    Real-World Atopic Dermatitis: Italian Insights Grant
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology Italy
    Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology All
    Optimizing Care for patients with Muscle Invasive Bladder Cancer (MIBC)
    Release Date:
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Canada
    Optimizing HRRm Testing and Workflow Integration in mCSPC
    Release Date:
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement, Research Oncology Canada
    Driving Timely Biomarker Testing to Optimize Treatment Decisions for Colorectal Cancer Patients Across Canada
    Release Date:
    Partner: Colorectal Cancer Canada (CCC)
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement, Research Oncology Canada
    Antimicrobial Stewardship —Treatment optimization under antibiotics appropriate use policy in China
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Optimizing maternal immunization practice in Saudi Arabia
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Vaccines Saudi Arabia
    Role of Maintenance Therapy in HER2+ Metastatic Breast Cancer (MBC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Projects of Equalization of Cancer Information
    Release Date:
    Partner: Japanese Society of Clinical Oncology
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Oncology Japan
    Initiatives for Healthcare Professionals to Promote Intramuscular Vaccination Methods for Children
    Release Date:
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Vaccines Japan
    Efforts to Improve Quality of Migraine Medical Care
    Release Date:
    Partner: The Japanese Headache Society
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Internal Medicine Japan
    Novel Therapies for Relapsed/Refractory Large B-Cell Lymphoma in Community Oncology Practice
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Improving the Care of Patients with Metastatic Breast Cancer (mBC) Through Innovative Strategies
    Release Date:
    Partner: The National Comprehensive Cancer Network® (NCCN)
    Review Process: Expert Review Panel
    Quality Improvement Oncology USA
    Improving Vaccination Systems and Environments to Promote prevention of Respiratory Infections in Older Adults
    Release Date:
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Vaccines Japan
    Clinical Research Capability Development in China
    Release Date:
    Review Process: Pfizer Internal
    Education Support for the Professions China
    Developing Educational Initiatives for Implementation and Therapy Management of BCMA BsAbs in RRMM
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Optimizing the Experience of Patients with Bladder Cancer Through Multi-Disciplinary Care
    Release Date:
    Partner: Conquer Cancer, the ASCO Foundation
    Review Process: Expert Review Panel
    Quality Improvement Oncology USA
    The Enhancement of Management of breast cancer in French speaking Sub-Saharan African Countries
    Release Date:
    Partner: AMFROM
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Benin, Congo, The Democratic Republic, Mali, Senegal, Togo